Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Barlow

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Acute Medicine|May 25, 2011
Prescribing at the coalface in the era of antimicrobial resistancePatrick Lillie, Gavin Barlow
Oxford Medical Case Reports|May 20, 2015
The rising tide of bloodstream infections with Actinomyces species: bimicrobial infection with Actinomyces odontolyticus and Escherichia coli in an intravenous drug userDaniel Weiand, Gavin Barlow
BMJ Case Reports|April 30, 2013
Nevirapine-induced Stevens-Johnson syndrome following HIV postexposure prophylaxisAyman Bannaga, Omar Rahama, Gavin Barlow
The Journal of Antimicrobial Chemotherapy|March 15, 2011
Diagnostic and prognostic biomarkers of sepsis in critical careSavitri Kibe, Kate Adams, Gavin Barlow
Advances in Clinical Chemistry|April 11, 2015
Procalcitonin: potential role in diagnosis and management of sepsisTim Rowland, Heather Hilliard, Gavin Barlow
Jac-Antimicrobial Resistance|July 25, 2022
PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemiaThomas Taynton, Gavin Barlow, David Allsup
Expert Review of Hematology|July 22, 2024
How can we optimize antifungal use and stewardship in the treatment of acute leukemia?Thomas Taynton, David Allsup, Gavin Barlow
Thorax|August 25, 2006
The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumoniaGavin Barlow, Dilip Nathwani, Peter Davey
British Journal of Hospital Medicine (London, England : 2005)|February 26, 2020
When are combinations of antibiotics clinically useful?Joshua A York, Maithili Varadarajan, Gavin Barlow
Jac-Antimicrobial Resistance|June 30, 2021
The impact of the COVID-19 pandemic on antimicrobial resistance: a debateDavid van Duin, Gavin Barlow, Dilip Nathwani
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Acute Medicine|May 25, 2011
Prescribing at the coalface in the era of antimicrobial resistancePatrick Lillie, Gavin Barlow
Oxford Medical Case Reports|May 20, 2015
The rising tide of bloodstream infections with Actinomyces species: bimicrobial infection with Actinomyces odontolyticus and Escherichia coli in an intravenous drug userDaniel Weiand, Gavin Barlow
BMJ Case Reports|April 30, 2013
Nevirapine-induced Stevens-Johnson syndrome following HIV postexposure prophylaxisAyman Bannaga, Omar Rahama, Gavin Barlow
The Journal of Antimicrobial Chemotherapy|March 15, 2011
Diagnostic and prognostic biomarkers of sepsis in critical careSavitri Kibe, Kate Adams, Gavin Barlow
Advances in Clinical Chemistry|April 11, 2015
Procalcitonin: potential role in diagnosis and management of sepsisTim Rowland, Heather Hilliard, Gavin Barlow
Jac-Antimicrobial Resistance|July 25, 2022
PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemiaThomas Taynton, Gavin Barlow, David Allsup
Expert Review of Hematology|July 22, 2024
How can we optimize antifungal use and stewardship in the treatment of acute leukemia?Thomas Taynton, David Allsup, Gavin Barlow
Thorax|August 25, 2006
The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumoniaGavin Barlow, Dilip Nathwani, Peter Davey
British Journal of Hospital Medicine (London, England : 2005)|February 26, 2020
When are combinations of antibiotics clinically useful?Joshua A York, Maithili Varadarajan, Gavin Barlow
Jac-Antimicrobial Resistance|June 30, 2021
The impact of the COVID-19 pandemic on antimicrobial resistance: a debateDavid van Duin, Gavin Barlow, Dilip Nathwani
Pageof 5